Urokinase-type Plasminogen Activator-like Proteases in Teleosts Lack Genuine Receptor-binding Epidermal Growth Factor-like Domains*
暂无分享,去创建一个
Mingdong Huang | M. Ploug | P. Andreasen | E. Baatrup | Niels Larsen | Thomas K Kristensen | J. Jensen | A. Christensen | L. Andersen | R. Bager | J. S. Johansen | Agnieszka Szczur
[1] B. Furie,et al. Structural Basis for Recognition of Urokinase-type Plasminogen Activator by Plasminogen Activator Inhibitor-1* , 2011, The Journal of Biological Chemistry.
[2] María Martín,et al. Ongoing and future developments at the Universal Protein Resource , 2010, Nucleic Acids Res..
[3] J. Kjems,et al. RNA aptamers as conformational probes and regulatory agents for plasminogen activator inhibitor-1. , 2010, Biochemistry.
[4] Mingdong Huang,et al. Structure-based Engineering of Species Selectivity in the Interaction between Urokinase and Its Receptor , 2010, The Journal of Biological Chemistry.
[5] P. Andreasen,et al. Nonproteolytic induction of catalytic activity into the single-chain form of urokinase-type plasminogen activator by dipeptides. , 2009, Biochemistry.
[6] I. Rodriguez,et al. Formyl peptide receptor-like proteins are a novel family of vomeronasal chemosensors , 2009, Nature.
[7] Nicholas H. Putnam,et al. The amphioxus genome and the evolution of the chordate karyotype , 2008, Nature.
[8] M. Ploug,et al. Structure and ligand interactions of the urokinase receptor (uPAR). , 2008, Frontiers in bioscience : a journal and virtual library.
[9] Y. Durocher,et al. Transfection of HEK293-EBNA1 Cells in Suspension with Linear PEI for Production of Recombinant Proteins. , 2008, CSH protocols.
[10] D. Shaw,et al. Structural basis of interaction between urokinase-type plasminogen activator and its receptor. , 2006, Journal of molecular biology.
[11] D. Dichek,et al. Mechanisms of Cardiac Fibrosis Induced by Urokinase Plasminogen Activator* , 2006, Journal of Biological Chemistry.
[12] D. Shaw,et al. Structure of Human Urokinase Plasminogen Activator in Complex with Its Receptor , 2006, Science.
[13] Torsten Schwede,et al. BIOINFORMATICS Bioinformatics Advance Access published November 12, 2005 The SWISS-MODEL Workspace: A web-based environment for protein structure homology modelling , 2022 .
[14] J. Budczies,et al. Gene expression patterns – a tool for bioanalysis , 2005 .
[15] Joaquín Dopazo,et al. PupasView: a visual tool for selecting suitable SNPs, with putative pathological effect in genes, for genotyping purposes , 2005, Nucleic Acids Res..
[16] Lina L. Feng,et al. Evolution of distinct EGF domains with specific functions , 2005, Protein science : a publication of the Protein Society.
[17] Tatiana A. Tatusova,et al. NCBI Reference Sequence (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins , 2004, Nucleic Acids Res..
[18] Charles E. Chapple,et al. Genome duplication in the teleost fish Tetraodon nigroviridis reveals the early vertebrate proto-karyotype , 2004, Nature.
[19] Robert C. Edgar,et al. MUSCLE: multiple sequence alignment with high accuracy and high throughput. , 2004, Nucleic acids research.
[20] L. Lutter,et al. Mutation of the highly conserved tryptophan in the serpin breach region alters the inhibitory mechanism of plasminogen activator inhibitor-1. , 2003, Biochemistry.
[21] R. Doolittle,et al. The evolution of vertebrate blood coagulation as viewed from a comparison of puffer fish and sea squirt genomes , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[22] Y. Durocher,et al. High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells. , 2002, Nucleic acids research.
[23] D. Church,et al. Spidey: a tool for mRNA-to-genomic alignments. , 2001, Genome research.
[24] H. Wergeland,et al. Studies of Atlantic salmon (Salmo salar L.) blood, spleen and head kidney leucocytes using specific monoclonal antibodies, immunohistochemistry and flow cytometry. , 2000, Fish & shellfish immunology.
[25] P. Gettins,et al. Serine 380 (P14) --> glutamate mutation activates antithrombin as an inhibitor of factor Xa. , 2000, The Journal of biological chemistry.
[26] D. Collen. The Plasminogen (Fibrinolytic) System , 1999, Thrombosis and Haemostasis.
[27] D. Birnbaum,et al. Ancient large-scale genome duplications: phylogenetic and linkage analyses shed light on chordate genome evolution. , 1998, Molecular biology and evolution.
[28] R. Norton,et al. Role of the 6‐20 disulfide bridge in the structure and activity of epidermal growth factor , 1998, Protein science : a publication of the Protein Society.
[29] M. Ploug,et al. Photoaffinity labeling of the human receptor for urokinase-type plasminogen activator using a decapeptide antagonist. Evidence for a composite ligand-binding site and a short interdomain separation. , 1998, Biochemistry.
[30] P. Carmeliet,et al. Receptor-independent Role of Urokinase-Type Plasminogen Activator in Pericellular Plasmin and Matrix Metalloproteinase Proteolysis during Vascular Wound Healing in Mice , 1998, The Journal of cell biology.
[31] R. Overbeek,et al. Searching for patterns in genomic data. , 1997, Trends in genetics : TIG.
[32] M. Duffy,et al. The urokinase‐type plasminogen activator system in cancer metastasis: A review , 1997, International journal of cancer.
[33] K. Danø,et al. Domain Interplay in the Urokinase Receptor , 1996, The Journal of Biological Chemistry.
[34] S. Moestrup,et al. The Multiligand α2‐Macroglobulin Receptor/Low Density Lipoprotein Receptor‐Related Protein (α2MR/LRP) , 1994 .
[35] W. Driever,et al. Characterization of a cell line derived from zebrafish (brachydanio rerio) embryos , 1993, In Vitro Cellular & Developmental Biology - Animal.
[36] K. Danø,et al. Diversity in catalytic properties of single chain and two chain tissue-type plasminogen activator , 1991 .
[37] P. Andreasen,et al. Lysosomal degradation of receptor-bound urokinase-type plasminogen activator is enhanced by its inhibitors in human trophoblastic choriocarcinoma cells. , 1990, Cell regulation.
[38] F. Sallés,et al. A plasminogen activator is induced during goldfish optic nerve regeneration. , 1990, The EMBO journal.
[39] L. Lund,et al. One-chain urokinase-type plasminogen activator from human sarcoma cells is a proenzyme with little or no intrinsic activity. , 1988, The Journal of biological chemistry.
[40] E. Appella,et al. Structure and function of epidermal growth factor‐like regions in proteins , 1988, FEBS letters.
[41] D. Belin,et al. Amiloride selectively inhibits the urokinase‐type plasminogen activator , 1987, FEBS letters.
[42] E. Appella,et al. The receptor-binding sequence of urokinase. A biological function for the growth-factor module of proteases. , 1987, The Journal of biological chemistry.
[43] Y. Wakamatsu,et al. Fish plasminogen activators: their identification and characterization. , 1987, Cell structure and function.
[44] G. Kaplan,et al. Salmonid macrophages: separation, in vitro culture and characterization , 1981 .
[45] D. Deutsch,et al. Plasminogen: Purification from Human Plasma by Affinity Chromatography , 1970, Science.
[46] P. Andreasen,et al. Biochemical properties of plasminogen activator inhibitor-1. , 2009, Frontiers in bioscience.
[47] R. Doolittle,et al. Step-by-step evolution of vertebrate blood coagulation. , 2009, Cold Spring Harbor symposia on quantitative biology.
[48] P. Carmeliet,et al. Modification of kidney barrier function by the urokinase receptor , 2008, Nature Medicine.
[49] R D Appel,et al. Protein identification and analysis tools in the ExPASy server. , 1999, Methods in molecular biology.
[50] P. Culp. Random DNA integrations as an approach to insertional mutagenesis in the zebrafish (Brachydanio rerio) , 1994 .